Tags

Type your tag names separated by a space and hit enter

Curcumin for parkinson´s disease: potential therapeutic effects, molecular mechanisms, and nanoformulations to enhance its efficacy.
Cell Mol Biol (Noisy-le-grand). 2021 Jan 31; 67(1):101-105.CM

Abstract

Parkinson's disease (PD) is one of the most prevalent neurodegenerative disorders worldwide. It is caused by the degeneration of dopaminergic neurons from the substantia nigra pars compacta. This neuronal loss causes the dopamine deficiency that leads to a series of functional changes within the basal ganglia, producing motor control abnormalities. L-DOPA is considered the gold standard for PD treatment, and it may alleviate its clinical manifestations for some time. However, its prolonged administration produces tolerance and several severe side effects, including dyskinesias and gastrointestinal disorders. Thus, there is an urgent need to find effective medications, and current trends have proposed some natural products as emerging options for this purpose. Concerning this, curcumin represents a promising bioactive compound with high therapeutic potential. Diverse studies in cellular and animal models have suggested that curcumin could be employed for the treatment of PD. Therefore, the objective of this narrative mini-review is to present an overview of the possible therapeutic effects of curcumin and the subjacent molecular mechanisms. Moreover, we describe several possible nanocarrier-based approaches to improve the bioavailability of curcumin and enhance its biological activity.

Authors+Show Affiliations

Laboratorio de Medicina Genómica, Departamento de Genómica, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Ciudad de México, 14389, Mexico. hcortes@inr.gob.mx.Laboratorio de Biologí-a Molecular del Cáncer, UMIEZ, Facultad de Estudios Superiores Zaragoza, Universidad Nacional Autónoma de México, 09230, Mexico City, Mexico. hcortes@inr.gob.mx.CONACyT-Laboratorio de Biotecnologí-a, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Ciudad de México 14389, Mexico. hcortes@inr.gob.mx.Laboratorio de Medicina Genómica, Departamento de Genómica, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Ciudad de México, 14389, Mexico. hcortes@inr.gob.mx.Departamento de Farmacia, Facultad de Quí-mica, Universidad Nacional Autónoma de México, Ciudad Universitaria, Ciudad de México 04510, Mexico. hcortes@inr.gob.mx.Facultad de Farmacia, Universidad Autónoma del Estado de Morelos, Cuernavaca 62209, Morelos, Mexico. hcortes@inr.gob.mx.Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. hcortes@inr.gob.mx.Laboratorio de Farmacogenética, UMIEZ, Facultad de Estudios Superiores Zaragoza, Universidad Nacional Autónoma de México, Ciudad de México 09230, Mexico. hcortes@inr.gob.mx.Facultad de Medicina, Universidad Veracruzana, Ciudad Mendoza, 94740, Veracruz, Mexico. hcortes@inr.gob.mx.Departamento de Fisiologí-a, Biofí-sica y Neurociencias, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Ciudad de México 07360, Mexico. hcortes@inr.gob.mx.Departamento de Farmacia, Facultad de Quí-mica, Universidad Nacional Autónoma de México, Ciudad Universitaria, Ciudad de México 04510, Mexico. hcortes@inr.gob.mx.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

34817361

Citation

Cortés, Hernán, et al. "Curcumin for Parkinson´s Disease: Potential Therapeutic Effects, Molecular Mechanisms, and Nanoformulations to Enhance Its Efficacy." Cellular and Molecular Biology (Noisy-le-Grand, France), vol. 67, no. 1, 2021, pp. 101-105.
Cortés H, Reyes-Hernández OD, Gonzalez-Torres M, et al. Curcumin for parkinson´s disease: potential therapeutic effects, molecular mechanisms, and nanoformulations to enhance its efficacy. Cell Mol Biol (Noisy-le-grand). 2021;67(1):101-105.
Cortés, H., Reyes-Hernández, O. D., Gonzalez-Torres, M., Vizcaino-Dorado, P. A., Del Prado-Audelo, M. L., Alcalá-Alcalá, S., Sharifi-Rad, J., Figueroa-González, G., González-Del Carmen, M., Florán, B. N., & Leyva-Gómez, G. (2021). Curcumin for parkinson´s disease: potential therapeutic effects, molecular mechanisms, and nanoformulations to enhance its efficacy. Cellular and Molecular Biology (Noisy-le-Grand, France), 67(1), 101-105. https://doi.org/10.14715/cmb/2021.67.1.15
Cortés H, et al. Curcumin for Parkinson´s Disease: Potential Therapeutic Effects, Molecular Mechanisms, and Nanoformulations to Enhance Its Efficacy. Cell Mol Biol (Noisy-le-grand). 2021 Jan 31;67(1):101-105. PubMed PMID: 34817361.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Curcumin for parkinson´s disease: potential therapeutic effects, molecular mechanisms, and nanoformulations to enhance its efficacy. AU - Cortés,Hernán, AU - Reyes-Hernández,Octavio D, AU - Gonzalez-Torres,Maykel, AU - Vizcaino-Dorado,Pablo A, AU - Del Prado-Audelo,Maria Luisa, AU - Alcalá-Alcalá,Sergio, AU - Sharifi-Rad,Javad, AU - Figueroa-González,Gabriela, AU - González-Del Carmen,Manuel, AU - Florán,Benjamí N, AU - Leyva-Gómez,Gerardo, Y1 - 2021/01/31/ PY - 2021/03/07/received PY - 2021/03/07/accepted PY - 2021/11/24/entrez PY - 2021/11/25/pubmed PY - 2022/3/8/medline SP - 101 EP - 105 JF - Cellular and molecular biology (Noisy-le-Grand, France) JO - Cell Mol Biol (Noisy-le-grand) VL - 67 IS - 1 N2 - Parkinson's disease (PD) is one of the most prevalent neurodegenerative disorders worldwide. It is caused by the degeneration of dopaminergic neurons from the substantia nigra pars compacta. This neuronal loss causes the dopamine deficiency that leads to a series of functional changes within the basal ganglia, producing motor control abnormalities. L-DOPA is considered the gold standard for PD treatment, and it may alleviate its clinical manifestations for some time. However, its prolonged administration produces tolerance and several severe side effects, including dyskinesias and gastrointestinal disorders. Thus, there is an urgent need to find effective medications, and current trends have proposed some natural products as emerging options for this purpose. Concerning this, curcumin represents a promising bioactive compound with high therapeutic potential. Diverse studies in cellular and animal models have suggested that curcumin could be employed for the treatment of PD. Therefore, the objective of this narrative mini-review is to present an overview of the possible therapeutic effects of curcumin and the subjacent molecular mechanisms. Moreover, we describe several possible nanocarrier-based approaches to improve the bioavailability of curcumin and enhance its biological activity. SN - 1165-158X UR - https://www.unboundmedicine.com/medline/citation/34817361/Curcumin_for_parkinson´s_disease:_potential_therapeutic_effects_molecular_mechanisms_and_nanoformulations_to_enhance_its_efficacy_ DB - PRIME DP - Unbound Medicine ER -